REQUEST A DEMO
Total
USD $0.00
Search more companies

Istanbul Depofarma Ilac Sanayi Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Istanbul Depofarma Ilac Sanayi Limited Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Istanbul Depofarma Ilac Sanayi Ltd. Sti. is a company in Turkiye, with a head office in Istanbul. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on January 28, 2014. It currently has a total number of 22 (2023) employees. In 2022, the company reported a net sales revenue increase of 63.27%. During that time, Istanbul Depofarma Ilac Sanayi Ltd. Sti.’s total assets grew by 32.05%. The net profit margin of Istanbul Depofarma Ilac Sanayi Ltd. Sti. decreased by 0.24% in 2022.

Headquarters
Barbaros Bulvari No:3 Serifali Mahallesi Mevdudi Sokak Umraniye
Istanbul; Marmara; Postal Code: 34775

Contact Details: Purchase the Istanbul Depofarma Ilac Sanayi Ltd. Sti. report to view the information.

Website: http://www.depofarma.com.tr

Basic Information
Total Employees:
Purchase the Istanbul Depofarma Ilac Sanayi Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Istanbul Depofarma Ilac Sanayi Ltd. Sti. report to view the information.
Incorporation Date:
January 28, 2014
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Istanbul Depofarma Ilac Sanayi Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
63.27%
Total operating revenue
63.27%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
9.64%
Total assets
32.05%
Total equity
3.5%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.24%
Return on Equity (ROE)
0.19%
Debt to Equity Ratio
-24.3%
Quick Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?